Longboard Pharmaceuticals, Inc.
USD59.98
CEO
Kevin R. Lind
IPO Date
2021-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Day Low
$59.98
Day High
$59.98
52W Low
$59.98
52W High
$59.98
Market Cap
$2.34B
| 363,740 |
| $60.00 |
| 2 Dec 2024 | Lind Kevin Robert | director, officer: President and CEO | D-Return | Disposed | 255,377 | $3.12 |
| 2 Dec 2024 | Lind Kevin Robert | director, officer: President and CEO | D-Return | Disposed | 192,783 | $4.20 |
| 2 Dec 2024 | Lind Kevin Robert | director, officer: President and CEO | D-Return | Disposed | 325,850 | $4.35 |
| 2 Dec 2024 | Lind Kevin Robert | director, officer: President and CEO | D-Return | Disposed | 332,134 | $19.32 |
| 2 Dec 2024 | Lind Kevin Robert | director, officer: President and CEO | D-Return | Disposed | 22,000 | $0.00 |
| 2 Dec 2024 | SEKHRI PAUL J | director | D-Return | Disposed | 25,461 | $3.62 |
| 2 Dec 2024 | SEKHRI PAUL J | director | D-Return | Disposed | 12,367 | $4.40 |
| 2 Dec 2024 | SEKHRI PAUL J | director | D-Return | Disposed | 12,500 | $7.06 |